0

CD85J/LILRB1 human

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATIAR42413207
Descriptionrecombinant, expressed in HEK 293 cells, ≥95% (SDS-PAGE)
Assay≥95% (SDS-PAGE)
Formlyophilized; observed mol wt 90-110 kDa (DTT-reduced. Protein migrates due to glycosylation. Gly 24 is the predicted N-terminal.); pkg of 50 μg
Impurity Content<1 EU/μg endotoxin (LAL test)
Size10UG, 50UG
Storage Conditions−20°C
1

Loss of the Immune Checkpoint CD85j/LILRB1 on Malignant Plasma Cells Contributes to Immune Escape in Multiple Myeloma

Ester Lozano, Tania Díaz, Mari-Pau Mena, Guillermo Suñe, Xavier Calvo, Marcos Calderón, Lorena Pérez-Amill, Vanina Rodríguez, Patricia Pérez-Galán, Gaël Roué, M Teresa Cibeira, Laura Rosiñol, Ignacio Isola, etc.

J Immunol. 2018 Apr 15;200(8):2581-2591.

PMID: 29531171

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode